Employee Stock Ownership Plans: Valuation, Fiduciary Duty, and the Leveraged ESOP Transaction

Document type: Article Practice area: Corporate — Employee Benefits Jurisdiction: United States (federal) Last reviewed: 5 September 2026

Two facts that explain everything else

An employee stock ownership plan is a defined contribution retirement plan designed to invest primarily in qualifying employer securities. That definition, which appears in 29 U.S.C. § 1107(d)(6) and in 26 U.S.C. § 4975(e)(7), is the source of nearly every distinctive feature of ESOP practice.

Fact one: the plan is deliberately undiversified. Every other retirement plan fiduciary is subject to the duty in 29 U.S.C. § 1104(a)(1)(C) to diversify plan investments so as to minimize the risk of large losses. ESOPs are expressly relieved of that duty as to qualifying employer securities by § 1104(a)(2), which also relieves the fiduciary of the ordinary prudence requirement only to the extent it requires diversification. Congress built a retirement plan on a concentrated position on purpose, as an ownership-transition and capital-formation policy.

Fact two: the plan's central transaction is a purchase from insiders. An ESOP acquires stock from the company's owners — frequently the founder, frequently a controlling shareholder, frequently people who also sit on the board and appoint the fiduciary. Section 1106 prohibits a fiduciary from causing the plan to engage in a sale or exchange of property with a party in interest, and from dealing with plan assets in his own interest. On its face, the transaction that defines an ESOP is a prohibited transaction.

What makes it lawful is a specific statutory exemption. Section 1108(e) exempts the acquisition or sale by a plan of qualifying employer securities if the acquisition or sale is for adequate consideration, no commission is charged, and — for a plan other than an eligible individual account plan — certain limits are met. The parallel excise tax exemption appears in 26 U.S.C. § 4975(d)(13).

"Adequate consideration" is defined in 29 U.S.C. § 1002(18) as, for an asset other than a security with a generally recognized market, the fair market value of the asset as determined in good faith by the trustee or named fiduciary pursuant to the terms of the plan and in accordance with regulations.

That is the whole ballgame. Every ESOP dispute, every Department of Labor investigation, and every fiduciary breach claim in this area reduces to a single question: did the trustee, acting prudently and in good faith, determine that the plan paid no more than fair market value?

Marchbank Structural

Marchbank Structural is a 340-employee steel fabrication business in Youngstown, founded in 1979 by Delphine Marchbank-Okoye, now 71, who owns 88% of the stock. Her two children work elsewhere. The management team has run the company for a decade.

Her options were a strategic sale to a competitor, a private equity recapitalization, or an ESOP. She chose the ESOP for reasons that are typical: she wanted the business to stay in Youngstown, she wanted the management team to continue, she wanted liquidity without a competitor learning her customer list, and — not least — the tax treatment was extraordinary.

What follows is her transaction, and it is a representative one.

The structure of a leveraged transaction

The basic mechanics. The company establishes an ESOP and a trust. The ESOP borrows money — the "inside loan" — from the company. The company funds that by borrowing from a bank — the "outside loan" — and often from the selling shareholder, who takes back a subordinated seller note. The ESOP uses the loan proceeds to buy stock from the selling shareholder. The purchased shares go into a suspense account and are released to participants' accounts over time as the inside loan is repaid, using employer contributions that are deductible under 26 U.S.C. § 404(a)(9).

Why the loan structure exists. An ESOP has no money. A leveraged structure lets the plan acquire a large block immediately and pay for it out of future company cash flow, with the shares allocated to employees as the debt amortizes.

The seller note and warrants. Bank financing rarely covers the full price, so the seller typically takes back a note — subordinated, at a stated rate, often with warrants attached to bring the seller's overall return to a market level for the risk assumed. Warrant structures are common, they are heavily negotiated, and they are one of the places the Department of Labor has looked closely, because a warrant that transfers too much future value back to the seller can mean the plan effectively paid more than the reported price.

Marchbank's deal: a purchase of 100% of the stock for $61 million, funded by $24 million of senior bank debt, $37 million of seller notes at 5% with warrants for 22% of the fully diluted equity, and a plan contribution schedule amortizing the inside loan over fifteen years.

Adequate consideration: the trustee, the appraiser, and the process

This is where transactions are defended or lost, and the distinction between the appraiser and the trustee is the distinction most often misunderstood.

The trustee makes the determination. Section 1002(18) assigns the good-faith fair market value determination to the trustee or named fiduciary. The appraiser advises. A trustee who receives a valuation report and signs the purchase agreement has not made a determination; it has ratified someone else's.

The trustee must be independent in fact. For a transaction with the selling shareholder, an inside trustee — an officer, a director, the seller's long-time counsel — is a fiduciary buying from his own employer's owner. Nearly every ESOP transaction of any size now uses an institutional independent trustee, retained for the transaction, with its own counsel and its own financial advisor. This is not a formality; it is the structural answer to § 1106.

What a prudent trustee process looks like:

Selection of the appraiser by the trustee, not by the company or the seller, with a documented selection process and an engagement running to the trustee.
Independent counsel to the trustee, separate from company counsel and seller's counsel.
A financial advisor to the trustee where the transaction warrants one.
Real diligence: financial, legal, operational, customer concentration, key person risk, environmental, litigation, and — critically — the reliability of management's projections.
Interrogation of the projections. Management projections drive the valuation. A trustee that accepts a hockey-stick forecast without testing it against history, industry data, and management's own track record has not been prudent. Ask what happened to last year's projections.
Negotiation. A trustee that accepts the seller's asking price has not negotiated. The file should show a bid, a counter, and a movement.
Documented deliberation. Minutes reflecting the questions asked, the answers received, the alternatives considered, and the basis for the conclusion.
A fairness opinion addressed to the trustee, opining that the consideration is not greater than fair market value and that the transaction is fair to the ESOP from a financial point of view.

The valuation itself. Standard methodologies — discounted cash flow, guideline public company, guideline transaction — with the specific ESOP considerations: control versus minority basis depending on what the plan is acquiring; marketability discounts, adjusted for the repurchase obligation and any put right; the treatment of the debt the transaction creates; the effect of warrants; and, where an S corporation election will follow, the treatment of the tax benefit.

Post-transaction valuations are required annually for plan administration, and they are performed by an independent appraiser under 26 U.S.C. § 401(a)(28)(C). The annual valuation determines participant account balances and the price at which the plan repurchases shares from departing participants, so it has real economic consequences year after year.

The tax provisions that drive the economics

ESOPs exist because of their tax treatment, and clients decide on the numbers.

Section 1042 deferral. 26 U.S.C. § 1042 permits a selling shareholder of a C corporation to elect nonrecognition of gain on a sale of qualified securities to an ESOP, if the ESOP owns at least 30% of the stock immediately after the sale, the seller has held the securities for at least three years, and the seller reinvests the proceeds in qualified replacement property — securities of domestic operating corporations — within a defined period beginning three months before and ending twelve months after the sale. Restrictions apply to allocations to the seller and related persons.

For Marchbank-Okoye, with a basis near zero and a $61 million sale, the deferral was worth an enormous amount and was the deciding factor.

Deduction of contributions. Section 404(a)(9) allows an employer to deduct contributions applied to repay an ESOP loan, including — within limits — contributions applied to principal. The company effectively deducts the purchase price of its own stock.

The S corporation feature. An ESOP is a tax-exempt shareholder. An S corporation's income passes through to its shareholders; income allocable to an ESOP is not currently taxable. A 100% ESOP-owned S corporation pays essentially no federal income tax on its operating income, which is the single most powerful feature in the structure and the reason most fully leveraged ESOP companies elect S status after closing.

The anti-abuse rule. Section 409(p) prevents S corporation ESOPs from being used to benefit a small group. It imposes a complex test on "disqualified persons" and "nonallocation years," with severe consequences — including excise tax and potential loss of the structure — if a nonallocation year occurs. This must be modeled before closing and monitored annually, particularly where synthetic equity such as warrants, options, or phantom stock is outstanding. Warrants issued to the seller are synthetic equity for this purpose, which is where the transaction structure and the anti-abuse rule collide.

Section 1042 is unavailable to S corporations, which is why sellers who want the deferral sell as a C corporation and the company converts afterward, subject to built-in gains considerations.

How Marchbank's transaction actually ran

Months 1–2: feasibility. Before any documents, an independent feasibility analysis: could the company service the debt an ESOP purchase would create, under a conservative case? Marchbank's advisor modeled three scenarios, including a two-year downturn matching 2009. The base case supported $61 million; the downturn case supported $52 million with a covenant breach in year three. That analysis set the negotiating range and, more importantly, became part of the trustee's file.

Month 2: the trustee. Marchbank-Okoye's counsel gave her the advice sellers resist: you do not choose the trustee, and you certainly do not choose the appraiser. The company's board — with Marchbank-Okoye recused from the appointment — retained an institutional trustee, which then retained its own counsel and its own valuation firm through a documented selection process.

Months 3–5: diligence and valuation. The trustee's team ran full diligence. Two findings mattered. Customer concentration was higher than management had presented — the top three accounts were 41% of revenue, not the 34% in the deck. And management's five-year projection assumed 7% annual growth against a ten-year historical average of 3.1%.

Month 5: the negotiation. The trustee's opening position, informed by those findings, was $52 million. Marchbank-Okoye's advisor had told her to expect $61 million. The gap took six weeks, three exchanges, and a restructuring of the seller note to close at $56.5 million, with warrants sized to bring the seller's blended return to a market level for subordinated risk.

This is the part sellers find hardest and counsel must insist on. A trustee that accepts the asking price has not negotiated, and a transaction with no negotiation history is the fact pattern the Department of Labor looks for. The $4.5 million reduction was, in Marchbank-Okoye's words, "the most expensive good advice I ever received" — and it is the reason the transaction has never been questioned.

Month 6: structure and closing. $22 million senior bank debt; $34.5 million seller notes at 5% with warrants for 19% of fully diluted equity; C corporation status preserved through closing to permit the § 1042 election; qualified replacement property identified in advance with the seller's investment advisor.

Month 7: post-closing. S corporation election effective the following year, with built-in gains modeled. A § 409(p) analysis run before the warrants were finalized, because warrants are synthetic equity and a nonallocation year would have been catastrophic. A repurchase obligation study commissioned at closing rather than in year ten.

Where it stands. Four years on, the company has paid down the bank debt on schedule, the annual valuation has risen, and 340 employees have retirement accounts they did not have before. Marchbank-Okoye deferred a very large capital gain and stayed on the board for three years.

The three decisions that made it defensible, in her counsel's assessment: an honest feasibility study before the price was set; a genuinely independent trustee with its own advisors; and a negotiation the file can prove.

The repurchase obligation, which is the liability nobody models

An ESOP company owes its departing participants cash for their shares, and that obligation grows for twenty years before anyone feels it.

Where it comes from. A participant in a plan holding employer securities that are not readily tradable on an established market has a put option to require the employer to repurchase distributed securities at fair market value, under 26 U.S.C. § 409(h). Distributions are triggered by retirement, death, disability, and other separations from service, on timelines the plan document sets within statutory limits.

Why it is dangerous. In the early years almost nobody leaves with a meaningful balance, so the obligation is invisible. Twenty years in, a cohort hired around the transaction retires at once, holding accounts that reflect two decades of share appreciation — and the company owes them cash in the same years its own capital needs are highest.

What a well-run sponsor does:

Commissions a repurchase obligation study at closing and refreshes it every two to three years, modeling participant demographics, turnover, share appreciation, and distribution timing over twenty-plus years.
Decides the funding strategy deliberately: pay from operating cash, sinking fund, corporate-owned life insurance, or recycling — having the plan buy the shares back with contributions rather than the company redeeming them, which keeps the share count constant and pushes value to remaining participants.
Uses the plan design levers available: distribution timing within statutory limits, installment payments where permitted, and the treatment of diversification elections.
Understands the feedback loop. Redemption reduces shares outstanding, which raises the per-share value, which raises the next cohort's balances. Recycling avoids that but requires ongoing contributions. Neither is free, and choosing by default is how companies find themselves borrowing to pay retirees.

And note the diversification right. Under 26 U.S.C. § 401(a)(28)(B), a qualified participant who has reached 55 with ten years of participation must be given the opportunity to diversify a portion of the account, on a defined schedule. That accelerates part of the obligation, and it must be in the model.

The fiduciary duties that continue after closing

The transaction ends; the fiduciary relationship does not.

Who the fiduciaries are. The trustee, the plan administrator or committee, and — importantly — whoever appoints and monitors them. The appointing fiduciary, typically the board, has a continuing duty to monitor the appointee's performance, and that duty is a recurring source of liability because boards appoint a trustee and never think about it again.

The duties. Section 1104(a)(1) requires a fiduciary to act solely in the interest of participants and beneficiaries, for the exclusive purpose of providing benefits and defraying reasonable expenses, with the care, skill, prudence, and diligence a prudent person acting in a like capacity and familiar with such matters would use — and in accordance with plan documents insofar as consistent with ERISA.

Prudence is about process. Hughes v. Northwestern University, 595 U.S. 170 (2022) rejected the notion that offering a range of prudent options excuses imprudent ones, reaffirming that fiduciaries have a continuing duty to monitor investments and remove imprudent ones — the principle established in Tibble v. Edison International, 575 U.S. 523 (2015), which held that the duty to monitor is a distinct, continuing duty with its own limitations analysis.

The stock-drop cases. Fifth Third Bancorp v. Dudenhoeffer, 573 U.S. 409 (2014) eliminated the presumption of prudence that had protected ESOP fiduciaries, holding that they are subject to the same duty of prudence as other fiduciaries except as to diversification. It then imposed a demanding pleading standard: for a publicly traded employer's stock, allegations that a fiduciary should have recognized from public information that the market was over- or undervaluing the stock are generally implausible; and where the claim rests on inside information, the plaintiff must plausibly allege an alternative action the fiduciary could have taken consistent with the securities laws that a prudent fiduciary would not have viewed as more likely to harm the fund than to help it. Amgen Inc. v. Harris, 577 U.S. 308 (2016) reinforced that the alternative-action element must actually be pleaded.

For a closely held ESOP company, the Dudenhoeffer market-efficiency reasoning does not apply, and the operative duties are the ones that matter every year: obtaining a competent independent annual valuation, monitoring the appraiser, administering distributions correctly, and — for the appointing fiduciary — monitoring the trustee.

And the liability is personal. Section 1109 makes a fiduciary personally liable to make good to the plan any losses resulting from a breach and to restore profits made through use of plan assets, with equitable and remedial relief available including removal. Section 1132 supplies the civil enforcement scheme, under which participants, other fiduciaries, and the Secretary of Labor may sue.

Enforcement, and what the government looks at

The Department of Labor has treated ESOP valuation as an enforcement priority for many years, and the pattern of its cases is consistent enough to be a checklist.

What draws attention: a purchase price materially above what the company's later performance supports; management projections that were never achieved and never tested; an appraiser selected and paid by the seller or the company rather than the trustee; a trustee with prior relationships with the seller; the absence of any negotiation; warrants or other seller consideration that shift value back after closing; and a transaction that leaves the company unable to service its debt.

The theory is nearly always the same: the plan paid more than adequate consideration, so the § 1108(e) exemption is unavailable, so the transaction was a prohibited transaction under § 1106, and the fiduciaries are liable under § 1109 for the overpayment plus lost earnings — with excise tax exposure under 26 U.S.C. § 4975 for the parties in interest.

The defense is the file. A trustee that can produce a documented selection process, independent counsel, real diligence, tested projections, a negotiation history, deliberative minutes, and a fairness opinion is in a fundamentally different position from one that can produce a valuation report and a signature page. The substantive question — was the price right — is contested by experts years later; the process question is answered by documents created contemporaneously or not at all.

Practical consequences for counsel. Build the file as though it will be produced, because it may be. Keep the trustee's deliberations privileged where possible while recognizing that fiduciary-communication doctrines may reach them. And advise sellers plainly that the price they want is not the price the trustee can pay — the trustee's duty runs to the plan, and a seller who pressures the process is creating a defect that will be litigated against the company the seller's employees now own.

Partial ESOPs, second-stage transactions, and exits

Not every ESOP buys the whole company, and an ESOP is not necessarily permanent.

The partial sale. A seller may sell 30% — the § 1042 threshold — or 49%, keeping control and taking some liquidity now. The advantages are a smaller debt burden and a seller who remains invested. The complications are real: the ESOP is a minority holder, the valuation applies minority and marketability discounts, and the plan's trustee is now a fiduciary for a minority stake in a company controlled by the person who sold it. Governance protections for the trustee — board representation, information rights, protective provisions — become important, and a trustee that accepts a minority position with no protections has a prudence problem.

The second-stage transaction. Many partial ESOPs are followed years later by a sale of the remaining shares to the plan. The second transaction is a fresh prohibited transaction requiring fresh adequate consideration analysis, a fresh trustee process, and fresh diligence — it does not inherit anything from the first. The most common error is treating stage two as an administrative follow-on.

Sale of an ESOP-owned company. An ESOP company can be sold, and this is where the pass-through voting right in 26 U.S.C. § 409(e) becomes operative: participants direct the vote of allocated shares on approval of a merger, sale of substantially all assets, and similar events. The trustee votes unallocated shares and must decide how to treat non-directed allocated shares under the plan's terms.

The fiduciary posture on a sale is the mirror of the purchase. The trustee is now selling, and its duty is to obtain no less than adequate consideration. That means a process: a real market check or auction, independent valuation, independent counsel, and documented deliberation. And it means scrutinizing anything that diverts value from the plan — management retention or transaction bonuses, rollover equity offered to executives, and indemnities. A buyer's offer of rich management incentives is a conflict the trustee must manage, not ignore.

Termination without a sale. A plan can be terminated and its assets distributed, which for a closely held company means the company must repurchase all the shares at once — usually the reason it does not happen.

And the failed ESOP. Where the debt cannot be serviced, restructuring involves lenders, the seller as a subordinated creditor, and a plan whose participants hold accounts in a company worth less than they were told. That situation generates the litigation that shapes this area, and it traces almost invariably to a feasibility analysis nobody ran honestly at the start.

Choosing an ESOP over the alternatives

For a client like Marchbank-Okoye the decision is comparative, and the honest comparison is worth making explicitly.

What an ESOP does better. It provides liquidity at fair market value without a competitor conducting diligence on the customer list. It permits § 1042 deferral for a C corporation seller, which can be worth more than a price premium. It keeps the business where it is, with the people who run it. It creates a tax-exempt operating structure if the company elects S status. And it is a genuine ownership benefit for employees, which for many sellers is the actual motivation.

What it does worse. The price is fair market value, not a strategic premium — a competitor with synergies can and often will pay more. The company takes on substantial debt and services it from cash flow. It acquires a permanent repurchase obligation. It becomes subject to ERISA, with annual valuations, plan administration, testing, and fiduciary exposure. Transaction costs are meaningful. And the seller's liquidity is often deferred into a subordinated note, which is a credit risk on the business the seller just sold.

When it does not work. A company with volatile or thin cash flow cannot service the debt. A company with heavy customer concentration will not support the valuation or the leverage. A business dependent on the departing owner's personal relationships will decline after closing, which harms the employees the structure was meant to benefit. And a seller who wants the maximum number should sell to a strategic buyer.

The disclosure obligation to the seller. Counsel advising the selling shareholder should say all of the above in writing. ESOP transactions are promoted energetically, and a seller who understands only the tax deferral has not been advised.

The transaction team, and who owes what to whom

ESOP deals fail on role confusion more than on any substantive question, because the same people occupy several chairs.

Company counsel represents the company. Not the seller, not the plan, not the participants. It drafts the plan, handles the corporate steps, and — importantly — advises the board in its capacity as appointing fiduciary, which is a fiduciary role.

Seller's counsel represents the seller, whose interest is the highest defensible price and the § 1042 election. That interest is legitimate and it is adverse to the plan.

Trustee's counsel represents the trustee, whose duty runs solely to plan participants under 29 U.S.C. § 1104. Separate firm, separate engagement, no prior relationship with the seller.

The appraiser is retained by and reports to the trustee. An appraisal commissioned by the company or the seller may inform the seller's expectations; it cannot support the trustee's adequate consideration determination.

The financial advisor to the trustee, where used, provides the fairness opinion.

The lender has its own counsel and its own credit view — which, usefully, is an independent test of the feasibility analysis.

Where it goes wrong. The founder's long-time lawyer drafts the plan, advises the board, and negotiates for the seller. An advisor originates the transaction, prepares the feasibility study, recommends the trustee, and earns a success fee. The appraiser has valued the company for the seller's estate planning for a decade and now values it for the plan. Each of these is a defect the Department of Labor will identify immediately, and none of them is necessary.

The clean structure costs more and takes longer, and it is what stands between the company and a decade of litigation. Tell the seller at the outset that the fees are higher because the process must be defensible, and that a defect discovered later costs the company — which by then the employees own — many multiples of the saving.

Feasibility: the analysis that should precede everything

Every failed ESOP traces back to a feasibility question nobody answered honestly, and the analysis is not complicated.

Can the company service the debt? Model the senior facility and the seller note against projected cash flow, under a base case, a management case, and — the one that matters — a downturn case calibrated to the worst two-year period in the company's actual history. If the downturn case breaches covenants, the leverage is too high, whatever the base case shows.

Is the cash flow the right kind? Stable, recurring, diversified revenue supports leverage. Project-based revenue with lumpy collections, heavy working capital swings, or a top-three customer concentration above roughly a third does not, regardless of the average.

Can the company fund the debt service and the contributions and the capital expenditure? ESOP contributions repaying the inside loan are cash out the door, deductible under 26 U.S.C. § 404(a)(9) but still cash. Companies that need to reinvest heavily to stay competitive frequently cannot do both, and the failure shows up in year four as deferred maintenance.

Will the business survive the owner's departure? If revenue depends on the seller's personal relationships, the projections supporting the valuation are wrong and the employees will bear it. Test this directly: which customers would leave, and what has been done to transition them?

Is there a management team? An ESOP has no controlling shareholder to intervene. A company without a capable, committed management team and a functioning board is a company with nobody in charge.

What does the repurchase obligation look like in twenty years? Model it now, per the study discussed above. A structure that works until the founding cohort retires is not a structure that works.

And who is running the analysis? A feasibility study prepared by the firm that will earn a fee if the transaction closes is worth reading with that in mind. The seller and the board should consider a genuinely independent look — and the trustee, when it arrives, will run its own regardless.

The honest counsel. If the answers are marginal, the right advice is a smaller partial sale, a longer amortization, a lower price, or a different exit. A transaction that closes and fails is worse for the employees than one that never happens.

What employees actually get, and how to explain it

An ESOP is sold to employees as ownership, and the gap between that word and the legal reality is the single largest source of dissatisfaction in these companies.

What a participant receives is an account in a retirement plan, credited with shares allocated according to the plan's formula as the internal loan amortizes, vesting on the plan's schedule, distributable on separation from service at the value fixed by the most recent independent appraisal, with a put right under 26 U.S.C. § 409(h) requiring the company to buy the shares for cash.

What a participant does not receive: stock they can sell, a dividend they can spend, a seat on the board, a vote on ordinary corporate matters, or a right to see the company's financial statements beyond what ERISA disclosure requires. Voting is passed through only on the major corporate events specified in 26 U.S.C. § 409(e).

The early-year disappointment is structural. In a leveraged transaction the shares sit in a suspense account and are released as the loan is repaid, so a participant's first several statements show a small balance in a company that has just been valued at tens of millions. Employees who were told "you now own the company" read that statement as a broken promise. Say at the outset that allocations build over the life of the loan, and show the projection.

The annual valuation will move, and sometimes down. A leveraged ESOP company is worth less immediately after closing than before, because of the debt. Explaining that in advance is far easier than explaining it after the first statement.

Communication practices that work: an annual meeting presenting the valuation with an explanation of what moved it; a plain-language summary of the plan alongside the required summary plan description; a personalized statement showing account value, vesting, and a projection; and a standing channel for questions that does not run through the person whose stock the plan bought.

And a caution for counsel. Enthusiastic communication about "ownership" and expected value creates expectations, and in the litigation that follows a disappointing outcome those communications are exhibits. Describe the plan accurately, describe the risks, and keep the deck.

Insurance, indemnity, and who actually bears the risk

Fiduciary liability under 29 U.S.C. § 1109 is personal, and the arrangements that address it are frequently misunderstood.

ERISA fiduciary liability insurance covers fiduciaries for breach claims. It is not the same as a fidelity bond, and companies regularly believe they have one when they have the other.

The bond is mandatory and does something different. Section 1112 requires every fiduciary and every person who handles plan funds to be bonded against loss by reason of fraud or dishonesty, generally in an amount not less than 10% of the funds handled, subject to statutory minimums and a cap. The bond protects the plan against theft; it does not protect the fiduciary against a prudence claim.

Indemnification has a hard limit. Section 1110 voids any provision that purports to relieve a fiduciary of responsibility or liability. Indemnification by the employer of a fiduciary is generally permitted — the fiduciary remains liable to the plan, and a third party pays — but indemnification by the plan is not. Draft accordingly, and check that the company's charter, bylaws, and trustee engagement letter do not purport to exculpate rather than indemnify.

The transaction-specific insurance. Representation and warranty style policies and specialized ESOP transaction liability products exist, addressing valuation and process risk. They are worth pricing, particularly where a seller is taking back a large note and would prefer not to fund a defense years later.

Who is exposed, in practice. The transaction trustee, for the purchase. The board, as appointing fiduciary, for selection and monitoring. The plan committee, for ongoing administration. The selling shareholder, as a party in interest, for excise tax under 26 U.S.C. § 4975 and as a potential defendant in a knowing-participation claim. And the company itself, which will fund the defense of all of them.

The practical instruction. Map the fiduciary roles in writing at closing — who is a fiduciary, for what function, appointed by whom, monitored how. Then confirm that each named person is covered by insurance that actually responds to the claim they are exposed to. That mapping takes an afternoon and is the document everyone reaches for when a claim arrives.

The plan document and administration, briefly

The transaction gets the attention; the plan runs for decades.

Eligibility, vesting, and allocation. Statutory minimums under 26 U.S.C. § 401(a), with allocation formulas typically based on compensation. Allocation of the released shares from the suspense account follows the plan formula as the inside loan amortizes.

Voting rights. Participants must be able to direct the voting of allocated shares on specified major corporate matters — approval of a merger, recapitalization, liquidation, sale of substantially all assets, and similar events — under 26 U.S.C. § 409(e). For a closely held company, that is the narrow set; ordinary director elections are generally directed by the trustee. Pass-through voting on a sale is the provision that matters, and it should be understood by the board long before a sale is contemplated.

Distributions. Timing rules keyed to separation from service and to loan repayment status, with the put option under § 409(h) and its payment terms.

Annual work. Independent appraisal under § 401(a)(28)(C); Form 5500 filing; nondiscrimination and coverage testing; § 409(p) testing for S corporations, including synthetic equity; participant statements; fiduciary committee meetings with minutes; and a repurchase obligation update.

And the governance overlay. An ESOP company has a board, a trustee, a plan committee, and a management team, with overlapping membership and genuinely different duties. Mapping who wears which hat, in writing, prevents the most common governance failure in these companies: a person acting as a fiduciary while thinking as an executive.